Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-03

Clinical Trial Update: Effect of Smoking Reduction on Endothelial Glucocalyx and Vascular Function [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating how smoking reduction affects endothelial glycocalyx and vascular function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Athens | Conditions: Smoking Cessation | Phase 4 | Status: UNKNOWN